Abstract
Endothelin-1 (ET-1), a peptide isolated from the culture medium of endothelial cells, mediates a variety of physiological and pathological responses including mitogenesis. We have compared the expression of ET receptors in untransformed versus ras-transformed NIH-3T3 murine fibroblasts and in untransformed versus SV40-transformed Wl38 (VA13) human fibroblasts by ligand binding and Northern analysis. NIH-3T3 and Wl38 cells displayed high affinity (200 and 220 pM) and high density (23,000 sites/cell and 14,000 sites/cell for NIH-3T3 and Wl38 cells, respectively) ET receptors. Competition binding experiments using subtype-selective ligands identified these receptors as the ETA subtype. Addition of ET-1 to the cells produced a concentration-dependent increase in intracellular calcium release. Both ras-transformed NIH-3T3 cells and SV40-transformed Wl38 cells (VA13) completely lacked [125I]ET-1 binding and failed to release calcium when exposed to ET-1. Northern analysis of the polyadenylat ed RNA (polyA RNA) isolated from untransformed and transformed cells revealed that the steady-state level of ETA receptor RNA was 90-95% less in transformed cells compared to untransformed cells. Thus, the loss of ET receptors as well as the receptor-mediated responses in transformed cells can be explained by down-regulation of ET receptor mRNA.
Similar content being viewed by others
References
Yanagisawa M, Kurihara S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Groto K, Maski T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411–415, 1988
Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Groto K, Masaki T: The human endothelin family. Three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86: 2863–2867, 1989
Kloog Y, Ambar I, Sokolovsky M, Kochva E, Wollberg Z, Bdolah A: Sarafotoxin, a novel vasoconstrictor peptide: phosphoinositide hydrolysis in rat heart and brain. Science 242: 268–270, 1988
Bloch KD, Friedrich SP, Lee ME, Eddy RL, Shows TB, Quertermous T: Structural organization and chromosomal assignment of the gene encoding endothelin. J Biol Chem 264: 10851–10857, 1989
Bloch KD, Eddy RL, Shows TB, Quertermous T: cDNA cloning and chromosomal assignment of the gene encoding endothelin-3. J Biol Chem 264: 18156–18161, 1989
Sakamoto H, Sasaki S, Hirata Y, Imai T, Ando K, Ida T, Sakurai T, Yanagisawa M, Masaki T, Marumo F: Production of endothelin-1 by rat cultured mesangial cells. Biochem Biophys Res Commun 169: 462–468, 1990
Ohta K, Hirata Y, Imai T, Kanno K, Emori T, Schichuri M, Marumo F: Cytokine-induced release of endothelin-1 from porcine renal epithelial cell line. Biochem Biophys Res Commun 169: 578–584, 1990
Auguet M, Delafotte S, Chabrier RE, Pirotzky E, Clostre F, Braquet P: Endothelin and Ca2+ agonist, Bay K8644: different vasoconstrictive properties. Biochem Biophys Res Commun 156: 186–192, 1988
Nambi P, Pullen M, Feuerstein G: Identification of endothelin receptors in various regions of rat brain. Neuropeptides 16: 195–199, 1990
Lysko P, Feuerstein G, Pullen M, Wu H-L, Nambi P: Identification of endothelin receptors in cultured cerebellar neurons. Neuropeptides 18: 83–86, 1991
Takayanagi R, Hashiguchi T, Ohashi M, Nawata H: Regional distribution of endothelin receptors in porcine cardiovascular tissues. Reg Peptides 27: 247–255, 1990
Nambi P, Pullen M, Wu H-L, Aiyar N, Ohlstein EH, Edwards RM: Identification of endothelin receptor subtypes in human renal cortex and medulla using subtype-selective ligands. Endocrinology 13: 1081–1086, 1992
Nambi P, Pullen M, Wu H-L, Bryan H, Elliott JD: Identification of endothelin receptor subtypes in rat kidney cortex using subtype-selective ligands. Mol Pharmacol 42: 336–339, 1992
Nambi P, Pullen M, Wu H-L, Nuthulaganti P, Elshourbagy N, Kumar C: Dexamethasone down regulates the expression of endothelin receptors in vascular smooth muscle cells. J Biol Chem 267: 19555–19559, 1992
Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S: Cloning and expression of a cDNA encoding an endothelin receptor. Nature 34: 730–732, 1990
Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Groto K, Masaki T: Cloning of a cDNA encoding a nonisopeptide-selective subtype of the endothelin receptor. Nature 348: 732–735, 1990
Lin YH, Kaji EH, Winkel GK, Ives HE, Lodish HF: Cloning and functional expression of a vascular smooth muscle endothelin receptor. Proc Natl Acad Sci USA 88: 3185–3188, 1991
Elshourbagy N, Korman DR, Wu H-L, Sylvester DR, Lee JA, Nuthulaganti P, Bergsma DJ, Kumar CS, Nambi P: Molecular characterization and regulation of the human endothelin receptors. J Biol Chem 268: 3873–3879, 1993
Williams DL, Jones KL, Pettibone DJ, Lis EV, Clinschmidt BV: Sarafotoxin 6c, an agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun 175: 556–561, 1991
Liu J, Casley DJ, Nayler WG: Ischemia causes externalization of endothelin-1 binding sites in rat cardiac membranes. Biochem Biophys Res Commun 164: 1220–1225, 1989
Nambi P, Pullen M, Contino LC, Brooks DP: Upregulation of renal endothelin receptors in rats with cyclosporine A-induced nephrotoxicity. Eur J Pharmacol 187: 113–116, 1990
Nambi P, Wu H-L, Lipshutz D, Prabhakar U: Identification and characterization of endothelin receptors on rat osteoblastic osteosarcoma cells: down regulation by 1,25-dihydroxy-Vitamin D3. Mol Pharmacol 47: 266–271, 1995
Albrightson C, Pullen M, Wu H-L, Dytko G, Hersh LB, Nambi P: Thrombin-mediated down-regulation of endothelin receptors in mesangial cells coincides with the down regulation of neutral endopeptidase activity. Mol Pharmacol 47: 1156–1163, 1995
Takuwa N, Takuwa Y, Yanagisawa M, Yamashita K, Masaki T: A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. J Biol Chem 264: 7856–7861, 1989
Ihara M, Noguchi K, Sacki T, Fukroda T, Tsuchida S, Kimura S, Fukami T, Ishikawa K, Nishikibe M, Yano M: Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci 50: 247–255, 1992
Aiyar N, Mattern MR, Hofmann GA, Edwards RM, Nambi P: Downregulation of CGRP-mediated cAMP accumulation in ras-transformed 3T3 fibroblasts. Ann NY Acad Sci 657: 449–451, 1992
Polverino AJ, Hughes BP, Barritt GJ: NIH-3T3 cells transformed with a ras oncogene exhibit a protein kinase C-mediated inhibition of agonist-stimulated Ca2+inflow. Biochem J 271: 309–315, 1990
Simonson MS, Wann S, Mene P, Dubyak GR, Kestel M, Nakazato Y, Sedor JR, Dunn MJ: Elevated levels of diacylglycerol and decreased phorbol ester sensitivity in ras-transformed fibroblasts. J Clin Invest 83: 708–712, 1989
Vigne P, Marsault R, Breittmayer JP, Frelin C: Enhancement of inositol phospholipid metabolism and activation of protein kinase C in ras-transformed rat fibroblasts. Biochem J 266: 415–420, 1990
Griendling KK, Tsuda T, Alexander RW: Endothelin stimulates phospholipase C, Na+/H+ exchange, c-fos expression and mitogenesis in rat mesangial cells. J Biol Chem 264: 8237–8240, 1989
Hirata Y, Takagi Y, Fukuda Y, Marumo F: Endothelin stimulates phosphatidylinositol hydrolysis and DNA synthesis in brain capillary endothelial cells. Atherosclerosis 78: 225–228, 1989
Nishizuka Y: The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334: 661–665, 1988
Woessner RD, Chung TDY, Hofmann GA, Mattern MR, Mirabelli CK, Drake FH, Johnson RK: Differences between normal and rastransformed NIH-3T3 cells in expression of the 170 Kd and 180 Kd forms of Topoisomerase II. Cancer Res 50: 2901–2908, 1990
Wolfman A, Macara IG: Endothelin is a potent mitogen for rat vascular smooth muscle cells. Nature (London) 325: 359–361, 1989
Huang M, Chida K, Kamata N, Nose K, Kato M, Homma Y, Takenawa T, Kuroki T: Endothelin stimulates diacylglycerol accumulation and activates protein kinase C in cultured vascular smooth muscle cells. J Biol Chem 263: 17975–17980, 1988
Nambi P, Aiyar N, Whitman M, Grier CE, Crooke ST: Homologous and heterologous desensitization mediated by vasopressin in smooth muscle cells. Cell Signal 1: 241–251, 1989
Grynkiewicz G, Poenie M, Tsien RY: A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440–3445, 1985
Chomczynski P, Sachi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159, 1987
Aviv H, Leder P: Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci USA 69: 1408–1412, 1972
Lehrarch H, Diamond D, Wozney JM, Boedtker H: RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination. Biochemistry 16: 4743–4751, 1977
Elshourbagy NA, Lee JA, Korman DR, Nuthulaganti P, DiLella AG, Sylvester DR, Sutiphong JA, Kumar CS: Expression cloning of porcine and human endothelin receptors. Circulation 84(Suppl. II): 1610 (abst.), 1991
Gunning P, Ponte P, Okayama H, Engel J, Blau H, Kedes L: Isolation and characterization of full-length cDNA clones for human α, βand γ-actin mRNAs: skeletal but not cytoplasmic actins have an amino terminal cysteine that is subsequently removed. Mol Cell Biol 3: 787–795, 1983
Feinberg AP, Vogelstein B: A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132: 6–13, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nambi, P., Mattern, M.R., Wu, HL. et al. Absence of endothelin receptors and receptor mRNA in mammalian fibroblasts transformed with SV40 or ras oncogene. Mol Cell Biochem 175, 29–35 (1997). https://doi.org/10.1023/A:1006827007251
Issue Date:
DOI: https://doi.org/10.1023/A:1006827007251